
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 21 March 2023
Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1134139
This article is a correction to:
High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
A Corrigendum on:
High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
by Wang X, Xing Z, Chen H, Yang H, Wang Q and Xing T (2022) Front. Oncol. 12:953529. doi: 10.3389/fonc.2022.953529
In the published article, there was an error in the Funding statement [LGH20H190003]. The correct Funding statement appears below.
This study has received funding from the following: Zhejiang Provincial Basic Public Welfare Research Project (LGF20H190003), Medical Health Science and Technology General Project of Zhejiang Provincial Health Commission (2020KY351), and Taizhou Science and Technology Planning Project of Zhejiang Province (1901ky02).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: hepatocellular carcinoma, nectin-1, prognostic, cell proliferation, metastasis
Citation: Wang X, Xing Z, Chen H, Yang H, Wang Q and Xing T (2023) Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma. Front. Oncol. 13:1134139. doi: 10.3389/fonc.2023.1134139
Received: 30 December 2022; Accepted: 20 January 2023;
Published: 21 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Wang, Xing, Chen, Yang, Wang and Xing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tongjing Xing, xingtj518@sina.com; Xuequan Wang, yantaiquan@126.com
†These authors share first authorship
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.